GRIFOLS | GRF - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Alcon AG USD 1.68B 16M 2026-06
Almirall EUR 429.87M 180.02M 2025-12
Amadeus IT EUR 754.9M 225.7M 2026-03
Amarin USD 23.17M 961K 2025-12
argenx SE USD 1.18B 40.98M 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Cie Automotive EUR 805.54M 79.61M 2024-12
Demant DKK 9.96B 1.13B 2026-06
Ence Energia y Celulosa EUR 64M 117.3M 2026-03
Essilor EUR 9.41B 1.12B 2026-06
Ferrovial EUR 4.27B 498M 2024-12
Fresenius EUR 1.55B 16M 2026-06
Fresenius Medical Care EUR 1.31B 130.98M 2026-06
Genmab DKK 1.07B 240M 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
GRIFOLS EUR 704M 84M 2026-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Inditex EUR 6.24B 878M 2026-06
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Merck EUR 3.17B 101M 2026-06
Novartis USD 11.24B 1.18B 2026-06
Philips EUR 2.15B 384M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
Smith & Nephew USD 2.09B 117M 2025-12
UCB EUR 3.19B 621M 2025-12
Viscofan EUR 112.29M 226K 2026-03